Novo Nordisk A/S - The Final Phase 3a Trial for IDegLira Completed, and FIAsp Approved for Phase 3 Development BAGSVAERD, DENMARK -- (Marketwire) -- 12/19/12 -- Company Announcement No 83 2012: http://hugin.info/2013/R/1666389/540820.pdf This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1666389] Novo Nordisk A/S Novo Alle , DK-2880 Bagsvaerd, Danmark *T. Tlf. +45 44 44 88 88 *F. Fax +45 44 44 49 05
Novo Nordisk A/S - The Final Phase 3a Trial for IDegLira
Press spacebar to pause and continue. Press esc to stop.